Results 11 to 20 of about 12,086 (99)

Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobulin treatment: a case study in Zhejiang Province, East China

Human Vaccines & Immunotherapeutics, 2020
Objective To evaluate the cost-effectiveness of the current strategy combining universal vaccination with hepatitis B immunoglobulin (HBIG) treatment for infants of hepatitis B surface antigen (HBsAg) positive mothers compared with universal vaccination ...
Yanbing Zeng, Mingliang Luo, Jianlin Lin, Hanqing He, Xuan Deng, Shuyun Xie, Ya Fang   +6 more
doaj   +1 more source

Predicting EQ-5D-5L Utility Scores from the Oswestry Disability Index and Roland-Morris Disability Questionnaire for Low Back Pain

Journal of Pain Research, 2020
Thomas G Poder,1– 3 Nathalie Carrier3 1School of Public Health, Department of Management, Evaluation and Health Policy, University of Montreal, Montreal, QC, Canada; 2Centre de recherche de l’Institut universitaire en santé mentale de ...
Poder TG, Carrier N
doaj  

Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation

Health Technology Assessment, 2013
Background: Dementia is one of the most common and serious disorders in later life and the economic and personal cost of caring for people with dementia is immense. There is a need to be able to evaluate interventions in dementia using cost-effectiveness
B Mulhern, D Rowen, J Brazier, S Smith, R Romeo, R Tait, C Watchurst, K-C Chua, V Loftus, T Young, D Lamping, M Knapp, R Howard, S Banerjee   +13 more
doaj   +1 more source

Estimating the range of incremental cost-effectiveness thresholds for healthcare based on willingness to pay and GDP per capita: A systematic review.

PLoS ONE, 2022
BackgroundDecision-making in healthcare policy involves assessing both costs and benefits. In determining the cost-effectiveness (CE) threshold, willingness to pay (WTP) per quality-adjusted life year (QALY), GDP per capita, and other factors are ...
Haru Iino, Masayuki Hashiguchi, Satoko Hori   +2 more
doaj   +2 more sources

A QALY is [still] a QALY is [still] a QALY?

BMC Medical Ethics
Despite clinical evidence of drug superiority, therapeutic modalities, like combination immunotherapy, are mostly considered cost-ineffective due to their high costs per life year(s) gained.
Hamideh Mahdiani, Nikolai Münch, Norbert W. Paul   +2 more
doaj   +1 more source

Determination of the reference value of the incremental cost-efficacy and cost-utility coefficient in Russia in oncology

Качественная клиническая практика, 2018
The share of antineoplastic drug dossiers submitted to reimbursement in Russia raised from 15% in 2014 to 28% in 2017. The effectiveness and safety of innovative anti-cancer therapy is higher comparing to widely used traditional treatments.
A. S. Kolbin, A. A. Kurylev
doaj   +1 more source

Epidemiological and pharmacoeconomic aspects of HIV infection in military

Журнал инфектологии, 2021
The goals of the research are to determine the latent morbidity and financial losses of the Russian Ministry of Defense due to the dismissal of service members with HIV infection at symptomatic stages; to establish the supposed clinical and ...
Yu. I. Bulankov, M. A. Bulygin, A. V. Bespalov, K. V. Zhdanov, A. A. Murachev, K. S. Ivanov, Yu. I. Lyashenko   +6 more
doaj   +1 more source

Review of methods for assessing the cost-effectiveness of medical interventions

Реальная клиническая практика: данные и доказательства
Assessment of the effectiveness of a drug is a complex process. Currently, the standard method for assessing the effectiveness of a medical intervention is the quality-adjusted life years (QALY).
T. I. Busheva, A. A. Kurylev
doaj   +1 more source

Modelling the Health Economic Impact of Influenza Vaccination Strategies for High-Risk Children in Vietnam [PDF]

Journal of Clinical and Diagnostic Research, 2018
Introduction: In Vietnam, since 2011 a National Influenza Surveillance System in Vietnam has implemented Severe Acute Respiratory Infection (SARI) surveillance to assemble information and inform administrational and methods of prevention.
Trung Quang Vo, Usa Chaikledkaew, Minh Van Hoang, Arthorn Riewpaiboon   +3 more
doaj   +1 more source

EVALUATION OF INGUINAL REPAIR EFFECTIVENESS BASED ON «COST-UTILITY» ANALYSIS

Сибирский научный медицинский журнал, 2019
Taking into account new technologies practical application, the evaluation of correlation between the expired costs and obtained utility for health is important today in the context of choice between open-cut and laparoscopic inguinal hernia treatment ...
A. N. Poborskiy, S. D. Asutaev
doaj   +1 more source